Jan 16, 2025 | False Claims Act
On January 15, 2025, the DOJ announced that its False Claims Act (FCA) recovery for fiscal year 2024 (which ended on September 30, 2024) exceeded $2.9 billion. This figure is slightly higher than the total recovery from the prior fiscal year ($2.7B) and the year...
Jan 14, 2025 | Administrative Law, False Claims Act, Fraud Investigations, Health Care, Health Care Fraud
Late last year, President Biden signed the annual National Defense Authorization Act (NDAA) for fiscal year 2025. This alone is not newsworthy, as this has happened every year since the NDAA was introduced in 1961. Generally speaking, the NDAA governs Department of...
Jan 8, 2025 | False Claims Act, Fraud Investigations
Although False Claims Act cases involving federal grant fraud may not be as common as those involving healthcare fraud, the consequences of such cases can be just as significant. Recently, Athira Pharma, a Washington state-based biopharmaceutical company, agreed to...
Sep 15, 2024 | DOJ, False Claims Act, Fraud Investigations, Health Care, Medicare and Medicaid
Late last week, the Department of Justice announced that Walgreen had agreed to pay over $106 million to resolve allegations that it violated the False Claims Act by billing government health care programs for prescriptions that were never dispensed. According to the...
Sep 9, 2024 | False Claims Act, Health Care, Health Care Fraud, Medicare and Medicaid
Late last month, the DOJ announced that St. Peter’s Health agreed to pay $10.8M to settle False Claims Act allegations. The settlement resolves claims that the organization submitted inaccurate information to federal healthcare programs, including Medicare and...
